ICC International Cannabis Corporation (CVE:ICC), a marijuana stock, climbed after Uruguay said sales of recreational cannabis will begin in July
Sean Mason | April 7, 2017 | SmallCapPower
A government go ahead was great news for shareholders of a marijuana stock Friday. Here’s some small stocks making big moves on Friday, April 7, 2017 (as of 4 pm EST):
Marijuana stock ICC International Cannabis Corporation (TSXV: ICC) jumped 11% to $1.13 on Friday after the Government of Uruguay announced that it expects sales of recreational cannabis will begin in July 2017, through registered pharmacies.
As well, shares of Prometic Life Sciences Inc. (TSX: PLI) rose as much as 1% before ending unchanged at $2.20 as the biopharmaceutical company said it has received a $9.5 million purchase order for the supply of affinity resin to an existing client.
Aurinia Pharmaceuticals Inc. (TSX: AUP), meanwhile, reported that it believes that the confirmatory data that can be generated from the single Phase III clinical trial (AURORA) and the recently completed AURA-LV (AURA) Phase IIb study should support regulatory submissions in the U.S., Europe and Japan for the development of voclosporin for the treatment of active lupus nephritis. Aurinia Pharmaceuticals stock moved up 7% to $9.44 following the announcement.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
Disclosure: Neither the author nor any of the principals at Small Cap Power, or their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below:
